Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 218 entries
View as:

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT04922021 Org: User:
Start: 07/14/21 End: 09/26/22 Due: 09/26/23

Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03442244 Org: User:
Start: 01/30/18 End: 02/20/18 Due: 02/20/19

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT01998984 Org: User:
Start: 01/31/14 End: 07/31/14 Due: 07/31/15

Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3

Phase: N/A Priority: Normal
NCT ID: NCT03363854 Org: User:
Start: 02/22/18 End: 09/26/19 Due: 09/26/20

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00403949 Org: User:
Start: 11/30/06 End: 03/31/07 Due: 03/31/08

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT02376049 Org: User:
Start: 02/28/15 End: 07/31/15 Due: 07/31/16

LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01536886 Org: User:
Start: 05/31/12 End: 11/30/12 Due: 11/30/13

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01293357 Org: User:
Start: 12/31/10 End: 12/31/10 Due: 12/31/11

Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02387853 Org: User:
Start: 03/31/16 End: 03/28/18 Due: 03/28/19

A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Phase: N/A Priority: Normal
NCT ID: NCT02392130 Org: User:
Start: 03/31/15 End: 06/30/15 Due: 06/30/16

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

Phase: N/A Priority: Normal
NCT ID: NCT01541553 Org: User:
Start: 03/31/12 End: 07/31/13 Due: 07/31/14

Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01195831 Org: User:
Start: 09/30/10 End: 03/31/11 Due: 03/31/12

A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04883333 Org: User:
Start: 05/17/21 End: 07/18/22 Due: 07/18/23

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

Phase: N/A Priority: Normal
NCT ID: NCT03526861 Org: User:
Start: 06/19/18 End: 03/16/21 Due: 03/16/22

Efficacy and Tolerability of Enstilar® in Daily Practice

Phase: N/A Priority: Normal
NCT ID: NCT02881346 Org: User:
Start: 09/30/16 End: 03/31/17 Due: 03/31/18

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01430312 Org: User:
Start: 09/30/11 End: 12/31/11 Due: 12/31/12

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

Phase: N/A Priority: Normal
NCT ID: NCT02602470 Org: User:
Start: 01/08/15 End: 03/10/16 Due: 03/10/17

The Real Life Topical Field Treatment of Actinic Keratosis Study

Phase: N/A Priority: Normal
NCT ID: NCT02362152 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

Assessment of the Phototoxic Potential of LEO 29102 Cream

Phase: N/A Priority: Normal
NCT ID: NCT00958516 Org: User:
Start: 09/30/09 End: 10/31/09 Due: 10/31/10

A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05050279 Org: User:
Start: 09/29/21 End: 01/04/22 Due: 01/04/23

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT02549339 Org: User:
Start: 11/13/15 End: 08/10/17 Due: 08/10/18

Fucidin® Cream in the Treatment of Impetigo

Phase: N/A Priority: Normal
NCT ID: NCT00986856 Org: User:
Start: 05/31/04 End: 03/31/05 Due: 03/31/06

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT02547363 Org: User:
Start: 11/30/15 End: 08/31/17 Due: 08/31/18

Study on Thrombosis Therapy in German Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01559883 Org: User:
Start: 02/29/12 End: 12/31/13 Due: 12/31/14

An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01837576 Org: User:
Start: 04/30/13 End: 06/30/13 Due: 06/30/14